Blood pressure lowering treatment in acute stroke
Metadata
Show metadataAppears in the following Collection
- Institutt for klinisk medisin [10814]
Abstract
No abstract.List of papers
Paper I: Sandset EC, Murray G, Boysen G, JatuzisD, Kõrv J, Lüders S, Richter P, Roine RO, Terént A, Thijs V, Berge E. Angiotensin receptor blockade in acute stroke. The Scandinavian Candesartan Acute Stroke Trial (SCAST): Rationale, methods and design of a multicentre, randomised- and placebo-controlled clinical trial (NCT00120003). Int J Stroke 2010; 5: 423-7. The paper is removed from the thesis in DUO due to publisher restrictions. The published version is available at: https://doi.org/10.1111/j.1747-4949.2010.00473.x |
Paper II: Sandset EC, Bath PMW, Boysen G, Jatuzis D, Kõrv J, Lüders S, Murray GD, Richter PS, Roine RO, Terént A, Thijs V, Berge E. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebocontrolled, double-blind trial. Lancet 2011; 377: 741-50. The paper is removed from the thesis in DUO due to publisher restrictions. The published version is available at: https://doi.org/10.1016/S0140-6736(11)60104-9 |
Paper III: Sandset EC, Murray GD, Bath PMW, Kjeldsen SE, Berge E; Relation between blood pressure in acute stroke and risk of early adverse events and poor outcome: the Scandinavian Candesartan Acute Stroke Trial. Stroke 2012; [E-pub ahead of print]. The paper is removed from the thesis in DUO due to publisher restrictions. The published version is available at: https://doi.org/10.1161/STROKEAHA.111.647362 |